
    
      The investigator will use next-generation targeted sequencing covering the entire ESR1
      ligand-binding domain (LBD) region to understand 1. the spectrum and prevalence of specific
      ESR1 mutation variants in Asian women, and 2. the preliminary correlation of Asian-specific
      prevalent ESR1 LBD mutation variants such as Y537C with treatment efficacy. For the second
      purpose, the investigator will specifically focus on patients with ESR1 Y537C mutation, while
      the results from patients with wild type ESR1 and patients with D538G or Y537S mutant will be
      severed as control for preliminary comparison.
    
  